Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.6
3.6
Journals
Diagnostics
Special Issues
Recent Advancements in MRI and PET/CT Technologies in the Field...
share announcement

Recent Advancements in MRI and PET/CT Technologies in the Field of Urologic Oncology

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 344

Special Issue Editor

Dr. Matteo Droghetti

E-Mail
Guest Editor
Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy
Interests: urologic oncology; prostate cancer; bladder cancer; PET/CT; MRI

Special Issue Information

Dear Colleagues,

This Special Issue, ‘Recent Advancements in MRI and PET/CT Technologies in the Field of Urologic Oncology’, aims to provide an overview of the recent technical developments in imaging for prostate cancer and their clinical relevance, with a special focus on MRI and PET/CT. This Special Issue aims to collate original papers, review articles, and case reports based on the clinical relevance and improvement achieved with the use of imaging modalities, such as PSMA PET/CT imaging , PSMA PET/MRI and whole-body MRI.

We would like to provide an enhanced and detailed overview of the state of the art of the clinical impact of these novel staging and re-staging tools as well as their pitfalls. Additionally, we will include a final discussion by experts in this field that summarizes and interprets the findings of this Special Issue concerning future developments and their potential applications.

Dr. Matteo Droghetti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • MRI
  • PET/CT
  • urologic oncology
  • prostate cancer
  • diagnostic imaging

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

10 pages, 264 KiB  
Review
Interpreting Prostate MRI Reports in the Era of Increasing Prostate MRI Utilization: A Urologist’s Perspective
by Kevin Miszewski, Katarzyna Skrobisz, Laura Miszewska and Marcin Matuszewski
Diagnostics 2024, 14(10), 1060; https://doi.org/10.3390/diagnostics14101060 - 20 May 2024
Viewed by 208
Abstract
Multi-parametric prostate MRI (mpMRI) is crucial for diagnosing, staging, and assessing treatment response in individuals with prostate cancer. Radiologists, through an accurate and standardized interpretation of mpMRI, stratify patients who may benefit from more invasive treatment or exclude patients who may be harmed [...] Read more.
Multi-parametric prostate MRI (mpMRI) is crucial for diagnosing, staging, and assessing treatment response in individuals with prostate cancer. Radiologists, through an accurate and standardized interpretation of mpMRI, stratify patients who may benefit from more invasive treatment or exclude patients who may be harmed by overtreatment. The integration of prostate MRI into the diagnostic pathway is anticipated to generate a substantial surge in the demand for high-quality mpMRI, estimated at approximately two million additional prostate MRI scans annually in Europe. In this review we examine the immediate impact on healthcare, particularly focusing on the workload and evolving roles of radiologists and urologists tasked with the interpretation of these reports and consequential decisions regarding prostate biopsies. We investigate important questions that influence how prostate MRI reports are handled. The discussion aims to provide insights into the collaboration needed for effective reporting. Full article
(This article belongs to the Special Issue Recent Advancements in MRI and PET/CT Technologies in the Field of Urologic Oncology)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop